SCHEMBL3864880

SCHEMBL3864880

[CH2]c1ccccc1SCCOC

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 8/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.44
▸ ALOX15 P16050 3/20 0.44
▸ POLB P06746 2/20 0.44
▸ PKM P14618 2/20 0.44
▸ MAP2K7 O14733 1/20 0.44
▸ CDC25A P30304 1/20 0.44
▸ CDC25B P30305 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 4/20 0.42
▸ TDP1 Q9NUW8 4/20 0.42
▸ ALOX12 P18054 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14734012 0.86 HSD17B10 (0.53) HSD17B10KMT2AALDH1A1ALOX15POLB
SCHEMBL7620846 0.78 KMT2A (0.48) HSD17B10KMT2AALDH1A1ALOX15POLB
SCHEMBL2959162 0.78 PTGS2 (0.47) ALDH1A1PKMLMNAHPGDTDP1
SCHEMBL23409813 0.77 ALDH1A1 (0.51) HSD17B10KMT2AALDH1A1ALOX15POLB
Ammonia Solution, Strong SCHEMBL27828064 0.77 PKM (0.48) HSD17B10KMT2AALDH1A1ALOX15POLB
SCHEMBL2974208 0.74 PTGS2 (0.51) ALDH1A1HTTLMNA
SCHEMBL2117748 0.74 HSD17B10 (0.44) HSD17B10KMT2AALDH1A1ALOX15POLB
SCHEMBL1017879 0.74 HSD17B10 (0.44) HSD17B10KMT2AALDH1A1ALOX15POLB
SCHEMBL2834162 0.73 S100A4 (0.35) HSD17B10ALDH1A1ALOX15PKMMAP2K7
SCHEMBL1025612 0.73 ALDH1A1 (0.64) HSD17B10KMT2AALDH1A1POLBMAP2K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131245-A1 IMINOPYRIDINE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 — — WO disclosed
Send feedback